NCT00771368View on ClinicalTrials.gov

Reduction of Bacteria in MRSA Positive Ulcers

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Leg UlcerPressure Ulcer
Interventions
DRUG

Nitric Oxide

1 % Gaseous Nitric Oxide, delivered for 30 minutes daily for 3 consecutive days

Trial Locations (1)

V5Z 1M9

Vancouver General Hospital, Vancouver

Sponsors
All Listed Sponsors
lead

Nitric BioTherapeutics, Inc

INDUSTRY

NCT00771368 - Reduction of Bacteria in MRSA Positive Ulcers | Biotech Hunter | Biotech Hunter